Axim Biotechnologies Inc (OTCQB:AXIM)

0.60
Delayed Data
As of Sep 24
 -0.005 / -0.83%
Today’s Change
0.39
Today|||52-Week Range
1.22
+38.63%
Year-to-Date
SECTOR
Industrial Services
INDUSTRY
Environmental Services
MARKET CAP
$80.0M

Company Description

AXIM Biotechnologies, Inc. operates as a biotechnology company. It focuses in the research, development and production of pharmaceutical, nutraceutical, cosmetic and genetically controlled botanical products. The firm also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand. The company was founded on November 18, 2010 and is headquartered in San Diego, CA.

Contact Information

AXIM Biotechnologies, Inc.
6191 Cornerstone Court East
San Diego California 92121
P:(858) 923-4422
Investor Relations:

Employees

Shareholders

Individual stakeholders30.53%
Mutual fund holders--
Other institutional--

Top Executives

John W. HuemoellerPresident, Chief Executive Officer & Director
Robert T. MalasekChief Financial Officer & Secretary
Joseph TauberChief Medical Officer
Jeffrey A. BusbySenior Vice President-Business Development